You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Polo-like Kinase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen

Recruiting
  • Recurrent Chronic Myelomonocytic Leukemia
  • Refractory Chronic Myelomonocytic Leukemia
  • Biospecimen Collection
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +11 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Mar 22, 2022

Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung

Unknown status
  • Non-Small Cell Lung Cancer
  • Tissue Collection
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Jan 28, 2021

Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

Recruiting
  • Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
  • No intervention; observational
  • Norcross, Georgia
    Center for Rare Neurological Diseases
Oct 20, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Boston, Massachusetts
  • +2 more
Jan 18, 2023

Xospata in Relapsed or Refractory Acute Myeloid Leukemia With

Recruiting
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Gilteritinib Exposure
  • Goyang-si, Gyeonggi-do, Korea, Republic of
  • +4 more
Aug 18, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)

Recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 29, 2022

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)

Terminated
Has Results
  • Rhabdomyosarcoma
  • +2 more
  • Los Angeles, California
  • +1 more
Mar 17, 2022

Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
  • Cincinnati, Ohio
  • +18 more
Jan 20, 2023

GilteRInf 2022 Study (Gilteritinib Related Infections)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Roma, RM, Italy
    Maria Ilaria Del Principe
Mar 17, 2023

sFlt- 1, PIGF, and Niacin Levels in Premature Ovarian

Completed
  • Premature Ovarian Insufficiency
  • ultrasound assessment
  • Gaziantep, Turkey
    Cengiz Gokcek Women's and Child's hospital
Aug 30, 2021

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

Not yet recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • (no location specified)
May 24, 2023

CDKL5 Disorder Trial (Ganaxolone)

Available
  • CDKL5 Disorder
  • (no location specified)
Apr 1, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

Available
  • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
  • (no location specified)
Oct 18, 2022

Patterns and Key Healthcare Resource Use in Acute Myeloid

Completed
  • Acute Myeloid Leukemia (AML)
  • Treatment patterns among AML patients
  • AML-related healthcare resources
  • Charlotte, North Carolina
    Sermo
Jan 25, 2022

Advanced/Metastatic Solid Tumors Trial in Frankston, Nedlands, Beijing (EMB07)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Frankston, Victoria, Australia
  • +2 more
Nov 3, 2022

The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or

Recruiting
  • Acute Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 28, 2022

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

CDKL5 Deficiency Disorder Trial (Ganaxolone, Placebo)

Not yet recruiting
  • CDKL5 Deficiency Disorder
  • (no location specified)
Feb 18, 2022

15q Duplication Syndrome, CDKL5 Deficiency Disease Trial in United States (Soticlestat)

Completed
Has Results
  • 15q Duplication Syndrome
  • CDKL5 Deficiency Disease
  • Los Angeles, California
  • +7 more
May 24, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Adenocarcinoma Trial in

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Questionnaire Administration
  • Tin Sn 117m Pentetate
  • Lexington, Kentucky
    University of Kentucky/Markey Cancer Center
Nov 26, 2022

Gestational Diabetes, Gestational Hypertension, Pre-Eclampsia Trial in Pisa

Recruiting
  • Gestational Diabetes
  • +2 more
    • Pisa, PI, Italy
      Azienda Ospedaliero-Universitaria Pisana - U.O. Malattie Metabol
    May 5, 2021

    Fetal Growth Retardation, Preeclampsia, Placenta Diseases Trial in Spain (soluble fms-like tyrosine kinase to placental growth

    Not yet recruiting
    • Fetal Growth Retardation
    • +2 more
    • soluble fms-like tyrosine kinase to placental growth factor ratio (sFlt-1/PlGF)
    • A Coruña, Spain
    • +23 more
    Mar 17, 2022